Comorbidities and body mass index in subjects with chronic obstructive pulmonary disease Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016
Body mass index, central obesity, and severity of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective Source: Eur Respir J 2003; 22: 2S-4S Year: 2003
Predictive accuracy of a simple functional index in chronic obstructive pulmonary disease Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015
Correlation between body mass index and spirometry parameters in chronic obstructive pulmonary disease patients with ischemic heart disease and obesity. Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019
A new multidimensional model for predicting mortality in COPD: body mass index and FEV1 quotient/MRC dyspnoea score (SID) Source: Annual Congress 2006 - COPD – the challenges for primary care Year: 2006
Associations between muscle wasting and BODE index in chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014
Study of inflammatory markers and BODE index in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016
Prospective study of body mass index and risk of adult-onset asthma or chronic obstructive pulmonary disease in women Source: Eur Respir J 2001; 18: Suppl. 33, 506s Year: 2001
Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016
Lung function and body weight influence the outcome of pulmonary rehabilitation in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 356s Year: 2001
Evidence of renal and pulmonary endothelial dysfunction in chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – New signalling pathways in COPD Year: 2016
Quantify comorbidities burden of chronic obstructive pulmonary disease patients using medication regimen complexity index Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016
Increased heart rate modulation, sympathetic dominance and systemic inflammation in chronic obstructive pulmonary disease Source: International Congress 2014 – Markers Year: 2014
Change in muscle mass in training patients with chronical obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 721s Year: 2005
The natural history of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=71 Year: 2006
Low body mass index in hospitalised patients with chronic obstructive pulmonary disease (COPD): is related to low lung function and increased mortality Source: Eur Respir J 2006; 28: Suppl. 50, 66s Year: 2006
Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD: points to ponder Year: 2014
Mortality associated with the type of heart failure in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016
Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD diagnosis Year: 2013